Andrea Alimonti

Bellinzona, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Corrigendum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [European Urology 83 (2023) 224-238.

Corrigendum to "B7-H3 as a Therapeutic Target in Advanced Prostate Cancer" [European Urology 83 (2023) 224-238.

Journal: European urology

Published: August 07, 2026

Prostate cancer: evading immunity, inspiring therapy.

Prostate cancer: evading immunity, inspiring therapy.

Journal: Trends in cancer

Published: March 23, 2026

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.

Journal: Investigational new drugs

Published: February 04, 2026

Challenges and advances in drug resistance and tolerance in cancer.

Challenges and advances in drug resistance and tolerance in cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 21, 2026

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanisms.

Journal: Pharmacological research

Published: October 30, 2025

Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.

Electrophilic compound screening identifies GPX4-dependent ferroptosis as a senescence vulnerability.

Journal: Nature cell biology

Published: September 10, 2025

Neutrophil maturation holds the secret to human tumor suppression.

Neutrophil maturation holds the secret to human tumor suppression.

Journal: Cell research

Published: August 01, 2025

Diagnostic Accuracy of Fully Hybrid PET/MRI with [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard.

Diagnostic Accuracy of Fully Hybrid PET/MRI with [68Ga]Ga-PSMA-11 and [68Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 25, 2025

Senescence in cancer.

Senescence in cancer.

Journal: Cancer cell

Published: February 19, 2025

N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity.

N-methyl-D-aspartate Receptors and Depression: Linking Psychopharmacology, Pathology and Physiology in a Unifying Hypothesis for the Epigenetic Code of Neural Plasticity.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: October 07, 2024

Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index.

Age- and sex-related variations in extracellular vesicle profiling for the assessment of cardiovascular risk: the EVaging index.

Journal: npj aging

Published: August 06, 2024

Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models.

Antitumor activity of PAbs generated by immunization with a novel HER3-targeting protein-based vaccine candidate in preclinical models.

Journal: Frontiers in oncology

Published: July 29, 2024

Showing 1-12 of 77

Last Updated: 09/26/2026